Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cristina, Berumen‐Glinz"'
Autor:
Zonía Robenne Moore, Dalit Zajdman-Faitelson, Arely Tamariz Campillo, Diana Karen Brito Bustillos, Sonia Toussaint-Caire, Cristina Berumen-Glinz
Publikováno v:
SAGE Open Medical Case Reports, Vol 11 (2023)
Nivolumab (PD-1 inhibitor) and ipilumumab (CTLA-4 inhibitor) are recently approved checkpoint inhibitors for treatment of non-small cell lung cancer. Immune-related adverse events related to the usage of checkpoint inhibitors are growing with their p
Externí odkaz:
https://doaj.org/article/b5a4d11710c548bfafce959eec397c5e
Autor:
Yolanda, Osorio‐Aragón I., Ximena, Milián‐Solís, Cristina, Berumen‐Glinz, Estefanía, Vargas C., Elisa, Vega‐Memije M., Jose, Andrade‐Rojas J., Fernanda, Contreras‐Solis M., Isaac, González‐Hernández
Publikováno v:
JEADV Clinical Practice; Jun2024, Vol. 3 Issue 2, p710-713, 4p
Autor:
Cristina Berumen-Glinz, Juan O. Colmenero-Mercado, Anais García-Domínguez, Luis E. Cano-Aguilar, María E. Vega-Memije
Publikováno v:
Revista Medicina Cut�nea Ibero-Latino-Americana. 51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f81ab8f0d5ef92e3baf58e379db7717
https://doi.org/10.24875/mcut.22000060
https://doi.org/10.24875/mcut.22000060
Autor:
Maria Caridad Duran-Lemarie, Luis Enrique Cano-Aguilar, Cristina Berumen-Glinz, Zonia Quijada-Ucelo, Heidi Hernandez-Ramirez, Mariana De Anda-Juárez, Elisa Vega-Memije
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::615404038c25a677a7517266bac38dc7
https://doi.org/10.7759/cureus.32729
https://doi.org/10.7759/cureus.32729
Publikováno v:
JAMA Dermatology. 158:586
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3e71f620b23349029c3e213ff1213ef
https://doi.org/10.1001/jamadermatol.2022.0154
https://doi.org/10.1001/jamadermatol.2022.0154